Next Article in Journal
Tegsedi (Inotersen): An Antisense Oligonucleotide Approved for the Treatment of Adult Patients with Hereditary Transthyretin Amyloidosis
Next Article in Special Issue
Targeting MMP-9 in Diabetic Foot Ulcers
Previous Article in Journal
Magnetic Graphene Oxide Nanocarrier for Targeted Delivery of Cisplatin: A Perspective for Glioblastoma Treatment
Review

The Expanding Role of MT1-MMP in Cancer Progression

1
Department of Chemistry & Biochemistry and the Center for Molecular Biology & Biotechnology, Florida Atlantic University, Jupiter, FL 33458 USA
2
Department of Chemistry, The Scripps Research Institute/Scripps Florida, Jupiter, FL 33458, USA
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2019, 12(2), 77; https://0-doi-org.brum.beds.ac.uk/10.3390/ph12020077
Received: 1 May 2019 / Revised: 16 May 2019 / Accepted: 18 May 2019 / Published: 20 May 2019
(This article belongs to the Special Issue Matrix Metalloproteinases)
For over 20 years, membrane type 1 matrix metalloproteinase (MT1-MMP) has been recognized as a key component in cancer progression. Initially, the primary roles assigned to MT1-MMP were the activation of proMMP-2 and degradation of fibrillar collagen. Proteomics has revealed a great array of MT1-MMP substrates, and MT1-MMP selective inhibitors have allowed for a more complete mapping of MT1-MMP biological functions. MT1-MMP has extensive sheddase activities, is both a positive and negative regulator of angiogenesis, can act intracellularly and as a transcription factor, and modulates immune responses. We presently examine the multi-faceted role of MT1-MMP in cancer, with a consideration of how the diversity of MT1-MMP behaviors impacts the application of MT1-MMP inhibitors. View Full-Text
Keywords: matrix metalloproteinase; extracellular matrix; cancer progression; immunosuppression; signal transduction; collagenolysis matrix metalloproteinase; extracellular matrix; cancer progression; immunosuppression; signal transduction; collagenolysis
Show Figures

Figure 1

MDPI and ACS Style

Knapinska, A.M.; Fields, G.B. The Expanding Role of MT1-MMP in Cancer Progression. Pharmaceuticals 2019, 12, 77. https://0-doi-org.brum.beds.ac.uk/10.3390/ph12020077

AMA Style

Knapinska AM, Fields GB. The Expanding Role of MT1-MMP in Cancer Progression. Pharmaceuticals. 2019; 12(2):77. https://0-doi-org.brum.beds.ac.uk/10.3390/ph12020077

Chicago/Turabian Style

Knapinska, Anna M., and Gregg B. Fields 2019. "The Expanding Role of MT1-MMP in Cancer Progression" Pharmaceuticals 12, no. 2: 77. https://0-doi-org.brum.beds.ac.uk/10.3390/ph12020077

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop